Evolent Health, Inc. EVH Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $151.86M+45.7% | $104.2M-46.0% | $192.83M+2.5% | $188.2M-29.3% | ||
| $26.13M-55.9% | $59.3M+331% | $13.77M-5.0% | $14.49M-80.9% | ||
| $18.52M-36.0% | $28.94M-4.6% | $30.33M+46.7% | $20.68M-59.8% | ||
| $506.37M-16.6% | $607.12M-11.2% | $683.67M+43.0% | $478.05M-8.8% | ||
| $80.79M+10.4% | $73.15M-6.4% | $78.19M-11.0% | $87.87M+8.0% | ||
| $4.37M-28.7% | $6.13M-48.8% | $11.98M-75.6% | $49.03M-2.3% | ||
| $694.48M-38.9% | $1.14B+1.9% | $1.12B+54.5% | $722.77M+69.5% | ||
| $584.94M-14.0% | $680.16M-9.6% | $752.01M+69.8% | $442.78M+58.3% | ||
| $13.54M+1.2% | $13.38M+10.4% | $12.12M-30.6% | $17.46M-46.5% | ||
| $8.97M+4.4% | $8.59M+75.4% | $4.9M+9.4% | $4.48M-18.0% | ||
| $1.9B-25.4% | $2.54B-5.1% | $2.68B+47.5% | $1.82B+28.0% | ||
| $59.78M-37.7% | $96.03M+99.0% | $48.25M-15.6% | $57.17M-40.5% | ||
| $50.99M+51.2% | $33.72M-40.2% | $56.39M+7.5% | $52.46M+1.2% | ||
| $1.2M-52.0% | $2.51M-58.0% | $5.98M+3.8% | $5.76M-51.8% | ||
| $15.34M-42.6% | $26.72M+174% | $9.74M+36.7% | $7.12M+0.7% | ||
| $385.26M-46.2% | $715.5M+6.1% | $674.24M+55.6% | $433.44M-2.7% | ||
| $7.51M-31.1% | $10.9M-18.1% | $13.31M+181% | $4.74M+238% | ||
| $970.54M+97.9% | $490.52M-17.8% | $597.05M+44.6% | $412.99M+91.5% | ||
| $3.82M-84.7% | $24.97M-34.3% | $38.01M-32.1% | $56.01M-3.0% | ||
| $19.16M-62.9% | $51.69M+8.2% | $47.75M-24.4% | $63.13M-2.6% | ||
| $8.01M+168% | $2.98M-18.0% | $3.64M-23.3% | $4.74M-14.2% | ||
| $1.48B+9.7% | $1.35B-5.7% | $1.43B+49.7% | $957.88M+32.0% | ||
| $1.18M+0.9% | $1.17M+1.0% | $1.15M+13.7% | $1.02M+11.8% | ||
| $1.79B-0.6% | $1.8B-0.2% | $1.81B+21.6% | $1.49B+10.9% | ||
| -$1.32B-68.5% | -$780.82M-8.6% | -$719.19M-18.6% | -$606.15M+3.3% | ||
| -$2.62M-49.7% | -$1.75M-39.5% | -$1.26M-6.7% | -$1.18M-225% | ||
| $61.43M+191% | $21.12M0.0% | $21.12M0.0% | $21.12M0.0% | ||
| $415.19M-58.5% | $1B-6.2% | $1.07B+24.2% | $859.42M+23.9% | ||
| $1.9B-25.4% | $2.54B-5.1% | $2.68B+47.5% | $1.82B+28.0% | ||
| $4.37M-28.7% | $6.13M-48.8% | $11.98M-75.6% | $49.03M-2.3% | ||
| $13.54M+1.2% | $13.38M+10.4% | $12.12M-30.6% | $17.46M-46.5% | ||
| $584.94M-14.0% | $680.16M-9.6% | $752.01M+69.8% | $442.78M+58.3% | ||
| $8.97M+4.4% | $8.59M+75.4% | $4.9M+9.4% | $4.48M-18.0% | ||
| $4.37M-28.7% | $6.13M-48.8% | $11.98M-75.6% | $49.03M-2.3% | ||
| $4.37M-28.7% | $6.13M-48.8% | $11.98M-75.6% | $49.03M-2.3% | ||
| $3.08M-13.8% | $3.57M-11.4% | $4.03M+69.4% | $2.38M-65.0% | ||
| $2.71M-82.0% | $15M-11.1% | $16.86M+35.3% | $12.47M-3.9% | ||
| $2.71M-82.0% | $15M-11.1% | $16.86M+35.3% | $12.47M-3.9% | ||
| $50.99M+51.2% | $33.72M-40.2% | $56.39M+7.5% | $52.46M+1.2% | ||
| $65.76M-0.9% | $66.36M-55.7% | $149.85M+34.8% | $111.2M+3.7% | ||
| $65.76M-0.9% | $66.36M-55.7% | $149.85M+34.8% | $111.2M+3.7% | ||
| $50.99M+51.2% | $33.72M-40.2% | $56.39M+7.5% | $52.46M+1.2% | ||
| $192.2M-39.7% | $318.71M-21.1% | $404.05M+102% | $199.73M+16.6% | ||
| $108.91M+0.7% | $108.11M+0.2% | $107.93M+135% | $45.95M— | ||
| $989.7M+38.7% | $713.67M+10.7% | $644.8M+35.4% | $476.12M+69.8% | ||
| $1.18M+0.9% | $1.17M+1.0% | $1.15M+13.7% | $1.02M+11.8% | ||
| $7.51M-31.1% | $10.9M-18.1% | $13.31M+181% | $4.74M+238% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Evolent Health, Inc.'s total assets?
- Evolent Health, Inc. (EVH) holds $1.9B in total assets, down 29.2% year over year.
- How much debt does Evolent Health, Inc. have?
- Evolent Health, Inc. carries $985.4M in total debt against $396.4M of shareholders' equity, a debt-to-equity ratio of 2.49.
- How much cash does Evolent Health, Inc. have?
- Evolent Health, Inc. holds $142.0M in cash and equivalents.
- Can Evolent Health, Inc. cover its short-term obligations?
- Its current ratio is 1.32 — current assets exceed current liabilities.
- Where does Evolent Health, Inc.'s balance sheet data come from?
- Every line is extracted from Evolent Health, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
